The legacy of Viagra, and its developer copyright, presents a complex case study for investors. Originally a blockbuster drug, generating billions in revenue , its intellectual property lapse created a flood of knock-off medications, significantly impacting its position . While specific businesses may attempt to capitalize on male sexual dysfunctio